Aquestive Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Conference
WARREN, N.J., Jan. 30, 2024 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ:AQST), a pharmaceutical company advancing medicines to bring meaningful improvement to patients’ lives through innovative science and delivery technologies, announced today that the management team will participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference on February 13th.
Related news for (AQST)
- Today’s Top Performers: MoBot’s Market Review 09/26/25 09:00 AM
- Today’s Top Performers: MoBot’s Market Review 09/04/25 07:00 PM
- MoBot’s Stock Market Highlights – 09/04/25 06:00 PM
- Aquestive Therapeutics Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for Anaphylm™
- 24/7 Market News Snapshot 04 September, 2025 – Aquestive Therapeutics, Inc. Common Stock (NASDAQ:AQST)